Habibe Karacay
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Organic Chemistry top 10%
- Co-authors
- David M. GoldenbergRobert M. SharkeyWilliam J. McBrideEdmund A. RossiChien‐Hsing ChangHans J. HansenChristopher D'SouzaGary L. Griffiths
- Topics
- Radiopharmaceutical Chemistry and Applications (38 papers)Monoclonal and Polyclonal Antibodies Research (37 papers)Peptidase Inhibition and Analysis (7 papers)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Habibe Karacay
42 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 72
- Radiology, Nuclear Medicine and Imaging 1.8k
- Oncology 668
- Molecular Biology 550
- Pulmonary and Respiratory Medicine 290
- Organic Chemistry 225
Countries citing papers authored by Habibe Karacay
This map shows the geographic impact of Habibe Karacay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Habibe Karacay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Habibe Karacay more than expected).
Fields of papers citing papers by Habibe Karacay
This network shows the impact of papers produced by Habibe Karacay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Habibe Karacay. The network helps show where Habibe Karacay may publish in the future.
Co-authorship network of co-authors of Habibe Karacay
This figure shows the co-authorship network connecting the top 25 collaborators of Habibe Karacay. A scholar is included among the top collaborators of Habibe Karacay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Habibe Karacay. Habibe Karacay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | 40 | |
| 3 | 17 | |
| 4 | 1 | |
| 5 | 12 | |
| 6 | A new tri-Fab recombinant bispecific antibody (bsMAb) for pretargeting epithelial cancers: Studies with TF12 and 111In-labeled hapten-peptide (IMP 288) in ovarian cancer | 3 |
| 7 | 324 | |
| 8 | 44 | |
| 9 | 37 | |
| 10 | 60 | |
| 11 | 53 | |
| 12 | 31 | |
| 13 | 122 | |
| 14 | 39 | |
| 15 | 103 | |
| 16 | Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates. | 50 |
| 17 | 43 | |
| 18 | 62 | |
| 19 | 12 | |
| 20 | 42 |
About Habibe Karacay
Habibe Karacay is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Biotechnology, having authored 42 papers that have together received 2.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (38 papers), Monoclonal and Polyclonal Antibodies Research (37 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.8k citations), Oncology (668 citations) and Immunology and Allergy (90 citations). Habibe Karacay has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include David M. Goldenberg, Robert M. Sharkey, William J. McBride, Edmund A. Rossi, Chien‐Hsing Chang, Hans J. Hansen, Christopher D'Souza, Gary L. Griffiths, Ivan D. Horak and Thomas M. Cardillo. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.